Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: RIPOR1

Gene summary for RIPOR1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

RIPOR1

Gene ID

79567

Gene nameRHO family interacting cell polarization regulator 1
Gene AliasFAM65A
Cytomap16q22.1
Gene Typeprotein-coding
GO ID

GO:0006810

UniProtAcc

Q6ZS17


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
79567RIPOR1S014HumanLiverHCC1.36e-214.94e-010.2254
79567RIPOR1S015HumanLiverHCC2.68e-225.12e-010.2375
79567RIPOR1S016HumanLiverHCC2.99e-154.13e-010.2243
79567RIPOR1S027HumanLiverHCC2.12e-218.82e-010.2446
79567RIPOR1S028HumanLiverHCC1.13e-277.50e-010.2503
79567RIPOR1S029HumanLiverHCC7.94e-237.10e-010.2581
79567RIPOR1male-WTAHumanThyroidPTC1.28e-069.98e-020.1037
79567RIPOR1PTC04HumanThyroidPTC4.82e-021.01e-010.1927
79567RIPOR1PTC05HumanThyroidPTC4.70e-031.52e-010.2065
79567RIPOR1PTC06HumanThyroidPTC5.78e-051.60e-010.2057
79567RIPOR1PTC07HumanThyroidPTC1.25e-051.49e-010.2044
79567RIPOR1ATC09HumanThyroidATC9.00e-082.68e-010.2871
79567RIPOR1ATC11HumanThyroidATC5.90e-107.74e-010.3386
79567RIPOR1ATC12HumanThyroidATC1.90e-142.82e-010.34
79567RIPOR1ATC13HumanThyroidATC1.17e-314.92e-010.34
79567RIPOR1ATC1HumanThyroidATC7.57e-093.11e-010.2878
79567RIPOR1ATC2HumanThyroidATC1.80e-126.31e-010.34
79567RIPOR1ATC3HumanThyroidATC3.69e-127.30e-010.338
79567RIPOR1ATC4HumanThyroidATC2.04e-173.42e-010.34
79567RIPOR1ATC5HumanThyroidATC1.84e-325.35e-010.34
Page: 1 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:005122234ThyroidATCpositive regulation of protein transport165/6293303/187234.94e-142.69e-12165
GO:0071496210ThyroidATCcellular response to external stimulus165/6293320/187232.01e-117.23e-10165
GO:000726524ThyroidATCRas protein signal transduction172/6293337/187232.25e-117.96e-10172
GO:003166927ThyroidATCcellular response to nutrient levels112/6293215/187231.57e-083.20e-07112
GO:003166827ThyroidATCcellular response to extracellular stimulus125/6293246/187231.65e-083.31e-07125
GO:004259424ThyroidATCresponse to starvation103/6293197/187234.59e-088.31e-07103
GO:000926724ThyroidATCcellular response to starvation85/6293156/187236.14e-081.09e-0685
GO:0031667210ThyroidATCresponse to nutrient levels212/6293474/187232.37e-073.70e-06212
GO:000726619ThyroidATCRho protein signal transduction73/6293137/187231.58e-061.93e-0573
GO:003406714ThyroidATCprotein localization to Golgi apparatus21/629329/187232.21e-051.96e-0421
GO:005164513ThyroidATCGolgi localization11/629314/187237.46e-044.14e-0311
Page: 1 2 3 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
Page: 1 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1